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Nanoparticles  possess  unique  properties  beyond  that  of classical  materials,  and  while these  properties
can  be  used  for  designing  a dedicated  functionality,  they  may  also  pose  a problem  to living organisms,  to
human  health  and  the  environment.  The  speciﬁc  primary  routes  by  which  nanoparticles  may  interact  with
the  human  body  include  inhalation,  injection,  ingestion  and  application  to the  skin.  Independent  of the
entry  route,  the  particles  inevitably  encounter  a complex  physiological  ﬂuid  populated  with  e.g.  proteins,
vitamins,  lipids  and  salts/ions.  Different  consequences  of such  an  encounter  may  include  formation  of
a  surface-bound  protein  layer,  particle  dissolution  or  aggregation,  which  are  expected  to  have  a  crucial
impact  on cellular  interaction.  Understanding  cellular  responses  to  nanoparticle  interactions  starts  with
understanding  particle behavior  in physiological  ﬂuids.  Nanoparticles  are  now  available  in practically  any
size,  shape  and  functionalization,  to promote  distinct  optical,  magnetic,  and  physico-chemical  properties,
making  the  prediction  of their  behavior,  in physiological  ﬂuids,  not  a trivial  task.  Characterization  has
therefore  become  of paramount  importance.  In  this  review,  we give  an overview  about  the  diversity  of
physiological  ﬂuids  as  well  as  present  an inventory  of the  most  relevant  experimental  techniques  used
to  study  plasmonic  nanoparticles.
1. Introduction
The development of “nano” started over 20 years ago, with
nanoscale science and technology now having an increasing impact
on many aspects of our daily lives. The enormous potential and
rapid expansion of nanotechnology has resulted in an exploding
array of engineered nanomaterials, which are  increasingly being
used for commercial purposes [1] but with clear differentiation
across industry sectors. Typically, materials applications are reach-
ing the markets ﬁrst, with electronics and IT applications following
closely behind [2]. Nanobiotechnology and nanomedicine have the
potential to revolutionize diagnostic tools and treatment strate-
gies, which are more personalized, efﬁcient, or easier to administer.
However, healthcare and life sciences applications have the longest
time-to-market: approval by  the regulatory agencies, technologi-
cal adjustments in manufacturing [3], and potential risks associated
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with engineered nanomaterials are  just some of the reasons for the
comparatively slow development of nanomedicines.
Nanoparticles (NPs) or sources of NPs can be classiﬁed as nat-
ural or intentional/engineered and unintentional anthropogenic
activities [4]. Humans can come in  contact with engineered NPs in
many  different ways such as through the use of consumer products
containing NPs (i.e.  food and cosmetic products), at the working
place (i.e.  occupational exposure), during disposal of the prod-
ucts (i.e.  incineration) or  by the intended use of NPs in  biomedical
applications. The possible portals where those NPs may  enter the
human body are the lungs via inhalation, the gastro-intestinal tract
via digestion, the skin, and blood vessels via intravenous injec-
tion [5]. No matter if the exposure is  intended or occupational,
NPs will interact at a certain time with the cells of the human
body. One particular fraction of engineered NPs may be deﬁned as
‘designer’ particles, having a desired functionality. These particles
are synthesized mostly within the walls of academic and research
centers laboratories generally aiming at obtaining uniform parti-
cles. In recent years, a  lot of progress was made in  the synthesis
of such designer NPs, which have been designed in many sizes
and morphologies [6–8] to produce distinct optical, magnetic, and
physico-chemical properties.
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Over the past two decades, much research has been dedicated to
the study of NP-cell interactions in  order to advance nanomedical
applications, while determining if the potential beneﬁts of nano-
technology could be achieved without any adverse impact upon
human health. More speciﬁcally, signiﬁcant effort has been dedi-
cated to elucidate the impact of physicochemical properties of NPs,
such as their size, surface charge, hydrophobicity or  shape, on their
interaction with cells. This interaction is  routinely assessed in vitro
to reveal mechanistic insights [9–11]. Despite the overwhelming
use of in vitro systems to evaluate cellular responses toward NPs,
the impact of an omnipresent complex physiological ﬂuid on the
material is still insufﬁciently taken into consideration [12–14].
2.  Physiological ﬂuids
Upon  contact with physiological ﬂuids, NPs can interact with a
wide range of biomacromolecules [15], with various consequences.
In order to understand the behavior of NPs in  physiological ﬂuids
it is imperative to summarize the composition of the non-cellular
compartments, such as mucus (gastro-intestinal (GI) or  respira-
tory tract) or aqueous lining layer covered by surfactant (lung
parenchyma), the blood or the lymphatic ﬂuid, as well as available
methods to investigate the possible interactions.
2.1. Mucus
Mucus is a biopolymer-based hydrogel produced by  speciﬁc
cells such as goblet cells and its main function is the protection of
epithelium against infectious agents. Mucus is rich in water (>95%)
and glycoproteins but also contains enzymes, immunoglobulins,
proteins and salts, with the composition varying between each
mucosal surface [16,17]. If particles are ingested or  inhaled, they
can be deposited onto the mucus, and through subsequent displace-
ment entrapped in mucin ﬁber mesh, depending on their size.
The  interaction of NPs with the mucus can cause a change
in particle size and zeta potential. The majority of experiments
to study these parameters are  usually performed using isolated
mucus collected from animals [18]. Recently it has been shown that
small-angle neutron scattering (SANS) is a  powerful technique to
investigate the interaction of mucus proteins/enzymes with NPs
and enables to correlate the changes in comparison to the bare
NPs  with mucus permeation [19]. Recently, a combination of tools,
such as cryo-scanning electron microscopy, capillary penetration,
and optical tweezers, was applied to assess particle mobility in
mucus and model hydrogels, and penetration of particles on various
length scales. It has been shown that particle mobility is  depend-
ent on the highly rigid structures within the mucus mesh but also
on the adhesive properties of the particles [20]. In addition to the
physicochemical parameters, the muco-adhesive properties of NPs
can be determined by applying rheological measurements [21].
Another possibility is  to use the Ussing chamber. With it,  it has
been demonstrated that the diffusion efﬁciency of neutral NPs was
higher in comparison to uncharged particles [22]. In addition, the
pH of mucus varies according to the location within the body, and
the interaction of NPs with the mucin polymers can be tuned by
buffer conditions such as pH and ionic strength [23].
The  respiratory tract is  covered by pulmonary surfactant, which
consists 85–90% of phospholipids and speciﬁc surfactant proteins
(SP) [24]. The binding of those constituents onto the surface of  a
NP can be determined by thin layer chromatography for lipids and
gel electrophoresis (SDS-Page) combined with liquid chromatog-
raphy/tandem mass spectrometry (LC/MS/MS). By using a  speciﬁc
ﬁxation method to stabilize the phospholipids and liquid lining
layer, Raemy et al. have shown that it is  possible to visualize NPs in
the aqueous lining layer (Fig. 1), indicating that this is an important
compartment where particle properties can change, depending on
the environment [25].
The  airway mucus varies in composition and amount along the
airway tree. The airway epithelial goblet cells and submucosal
glands secrete mucus, forming a  two-layer mucus blanket over
the ciliated epithelium, i.e. a  low-viscosity sol layer covered by  a
high-viscosity gel layer and a glycocalyx [26]. Insoluble particles
are trapped in the gel layer and are moved toward the pharynx
(and ultimately to  the GI tract) by the upward movement of mucus
generated via metachronous beating of the cilia also known as
mucociliary clearance. The aqueous lining layer height in the lung
parenchyma is  very thin, i.e. about 5 m as reported for primary
human epithelial type II  cells in  culture [27], therefore, the volume
is also very small and makes it difﬁcult to collect it in vitro or in vivo
to determine the colloidal behavior of NP in this liquid. An alterna-
tive approach is to use artiﬁcial alveolar ﬂuid, and it has been shown
that incubation of this liquid with silver NPs induces aggregation
Fig. 1. TEM micrograph of a human epithelial II cell  in  vitro (A549 cells) incubated at the air–liquid interface and exposed to  aerosolized NPs (inset). After 10 min  of incubation
the  NPs are mainly localized in the aqueous lining layer formed by the cells before they are internalized.
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which was conﬁrmed by transmission electron microscopy and
dynamic light scattering experiments [28].
2.2. Blood
The main administration route up to date for biomedical NPs
such as theranostic NPs is  via intravenous injection [29], where
the NPs encounter a complex cellular and molecular milieu of the
human blood [30]. The human blood is  composed of a  cellular
fraction (∼45%), i.e. red blood cells, white cells and platelets, and
the blood plasma (∼55%) with proteins, glucose, amino acids, fatty
acids and others such as clotting proteins, i.e. ﬁbrinogens. The term
“blood serum” refers to plasma from which ﬁbrinogen has been
removed. Blood contains more than 1000 types of proteins and over
50 of them have been identiﬁed in various experiments on the sur-
face of NPs [15,31]. Recent ﬁndings have also shown that incubating
NPs with human plasma, from subjects with different diseases and
medical conditions, results in protein coronas of different composi-
tion [32]. Since blood composition is highly complex, the analysis of
the NP behavior in complete (human) blood is very challenging and
the studies are usually done in vitro using deﬁned suspension con-
ditions and/or in vivo experiments (for a  review see Hall et al. [33]).
Indeed, most research is focused on the identiﬁcation of surface
adsorbed proteins on NPs with respect to their physicochemical
properties [34].
One  approach to characterize aggregation and the proteins
adsorbed onto the surface of magnetic NPs is to separate the NP-
protein complex after injection into the blood stream of rats by a
high magnetic ﬁeld gradient magnetic reactor [35]. It was  reported
that the protein composition depends on the initial surface charge
of different functionalized NPs [36]. By using a  similar approach,
i.e. incubation of magnetic NPs with 10% fetal bovine serum and a
subsequent isolation using a  magnetic reactor, the size and surface
charge were characterized using dynamic light scattering. Although
the adsorbed protein proﬁle was similar on differently charged NPs,
the positively charged NPs displayed signiﬁcantly lower colloidal
stability [37].
2.3.  Lymph ﬂuid
Lymph  ﬂuid is  formed by interstitial ﬂuid collection through
the lymph capillaries and is then transported via the lymph ves-
sels to the lymph nodes. The composition of lymph is  similar to
blood plasma but contains only white blood cells. Since NPs have
been observed in the lymph nodes, a  transport from the primary
barriers into the lymph capillaries must have occurred [38,39].
This transport might occur via single NPs, small aggregates, or NPs
inside immune cells, i.e.  dendritic cells. Although it has been shown
recently in vivo that the transport of quantum dots from the vaginal
lumen to the lymph nodes can be explained by  convective diffu-
sion from the interstitial ﬂuid into the lymph capillaries [40], the
colloidal characteristics of NPs in this physiological ﬂuid are still
unknown and more research in this area is needed.
2.4. Cell culture media
Since  the mucus and blood ﬂuids are incredibly complex and the
vast majority of studies in  the ﬁeld are done in vitro, most research
to assess the colloidal behavior of NPs in physiological ﬂuids are
done in complete, i.e. serum supplemented cell culture media.
Depending on cell type, a  speciﬁc medium is used to culture cells
in vitro. We  refer the reader to specialized reviews [41] that describe
the composition between the most common cell culture media.
Fig.  2 schematically shows the crowded environment of a  NP
(represented as 40 nm Au sphere) in  a  standard complete cell
culture medium (e.g. Dulbecco/Vogt modiﬁed Eagle’s medium
(DMEM) supplemented with 10% fetal bovine serum (FBS)). The
Fig. 2. Scaled illustration of an Au NP incubated into 10% serum-supplemented cell
culture medium. Scale ratio 1:2.5 ×  1018 based on  the volume occupied of 250 L in
a 96-well plate.
medium can be described as a buffered solution containing proteins
such as serum albumin, globulins, other biomolecules such as vita-
mins and amino acids, and ionic salts. The box (cube with 100 nm
side length) represents the volume of medium in which only one NP
(at an incubation concentration of 20 g/mL) is present. The envi-
ronment of the NP in this box includes roughly 6400 amino acids,
almost 100 vitamin molecules and more than 240,000 ions (cations
and anions), represented as green dots, in addition to roughly 34
proteins.
Thus, NP behavior in  such an environment will be  dictated by  the
interaction with these components. This interaction can have major
consequences, some of which are  schematically shown in Fig. 3.
First, it can result in  a  tightly bound immobile protein layer
formed on the particle surface (the so-called hard corona) and pos-
sibly a weakly associated mobile layer (the soft corona) [42]. Many
studies have focused on identifying the major protein constituents,
with the protein corona having shown to be determined by one
or more characteristics of the NP, such as material composition,
size, hydrophobicity, or charge [37,42]. Much of the information
regarding the interaction of proteins and NPs have been summa-
rized in several excellent reviews, which the reader is  referred to
[15,43].
Second, the interaction of NPs with physiological ﬂuids can
induce NP aggregation, which is  a common phenomenon in  this
complex environment and should therefore be taken into account
[44]. Aggregation refers to the, usually irreversible, inter-particular
adherence, leading to the formation of large and irregularly shaped
clusters [45]. This aggregation can lead to misrepresentative results
and hamper experimental reproducibility [12]. For example, Wick
et al. observed a more pronounced cytotoxic effect for aggregated
carbon nanotubes compared to bundled carbon nanotubes, con-
ﬁrming the hypothesis that aggregation phenomena occur and can
modify the cytotoxicity of a nanomaterial [46]. Cho and colleagues
[9] showed, by using an upright and an inverted cell culture conﬁg-
uration, that the cellular uptake of gold NPs was  generally higher
in the upright conﬁguration and that cellular uptake between the
two conﬁgurations was most prominent for gold NPs with higher
sedimentation rates. This additionally highlights the necessity of
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Fig. 3. Schematic illustration of possible consequences arising from NP  incubation in physiological ﬂuids. (A) Formation of protein corona; (B) NP  aggregation; (C) NP
dissolution; (D) removal/exchange of anchoring ligands.
taking into account sedimentation and diffusion, which can vary
wildly for aggregates. In  a  recent review, we have described the
current state-of-the art, the theory behind it, current bottlenecks
in this ﬁeld [41].
Third,  some NPs, in  particular silver (Ag) and copper (Cu), have
been reported to undergo oxidative dissolution. Ion release was
found to correlate with intrinsic NP properties, such as particle size,
shape and surface coating, but also with matrix factors, such as
dissolved oxygen, temperature, pH, ionic strength and the presence
of proteins [47–49]. For example, Ostermeyer et al. have shown that
increased concentrations of bovine serum albumin (BSA) result in
increased dissolution rates of Ag NPs due to the high afﬁnity of BSA
toward Ag+ ions chemisorbed on the Ag NP surface [48].
Finally,  the presence of biomolecules was reported to be respon-
sible for the removal of anchoring ligands from NP surfaces. Several
studies have shown that physiological concentrations of thiol-
containing molecules such as cysteine easily displace, for example,
thiolated Polyethylene-glycol (PEG) from the surface of Au NPs
[50,51]. The (partial) loss of the ligand, however, has far-reaching
consequences as it  impacts colloidal stability of the core NP,
changes the adsorbed protein proﬁle, and may  lead to the com-
plete loss of any functional grafted ligands such as ﬂuorescent dyes,
antibodies, or drug molecules.
3. Characterization of NPs in physiological ﬂuids
The  characterization of NPs in physiological ﬂuids and the
assessment of their colloidal behavior are challenging due to the
complex physical and chemical forces involved, the multitude of
different, highly complex physiological ﬂuids, and the variety and
complexity of analytical methods and theories upon which these
methods are based. However, there are some techniques that are
regularly used to study the behavior of NPs in complex ﬂuids, as
well as a growing number of novel methods that have emerged
in recent years. Here we discuss the most commonly used exper-
imental techniques and comment on considerations that must be
made when characterizing such complex systems. It is important
to mention that most of the research in this area is  performed with
NPs in  serum completed cell culture media since the composition
of this ﬂuid can be controlled.
In  this review, we focus on metallic NPs, most frequently silver
(Ag) and gold (Au), which exhibit outstanding physical and chemi-
cal properties that are markedly different from the bulk metal [52].
The most important property of these NPs is the so-called local-
ized surface plasmon resonance (LSPR) which is generated by  the
collective oscillation of conduction band electrons upon excitation
with the appropriate electromagnetic radiation (e.g.  a  laser beam),
resulting in  a  characteristic light scattering and absorption spec-
trum, which is a  function of the particle size, morphology, and the
local dielectric environment [53,54]. This consequently makes plas-
monic NPs excellent probes for many analytical techniques that rely
on light scattering and absorption. Due to their outstanding opti-
cal properties, an increasing number of studies have focused on Au
for a  wide range of biological and biomedical applications such as
biosensing, biomedical imaging, gene and drug delivery, or  disease
detection [55,56].
Tables  1 and 2 summarize typical NPs, organized by the main
analytical method used to characterize them in  a  variety of
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Table  1
Dynamic light scattering of typical plasmonic NPs in a  variety of physiological ﬂuids.
Reference NP type Fluid(s) Content
Albanese (2011) [57] Au NPs and TF coated Au aggregates RPMI Effect of aggregation on  cellular uptake
and cytotoxicity
Balog  (2015) [58] Au NPs (citrate, COOH-PEG, NH2-PEG
and  methoxy-PEG coated)
DMEM,  DMEM containing 10%FBS Characterizing state of aggregation in
physiological ﬂuid
Braydich-Stolle (2014) [28] Ag NPs (Bare and polysaccharide coated) Alveolar and lysosomal ﬂuid Stability and aggregation
Casals (2010) [59] Au NPs Complete cell media Evolution of protein corona
Casals (2011) [60] Au and Ag NPs Complete cell media Protein corona formation and biological
implications
Cho  (2011) [9] Au NPs (bare and PEG coated) Complete cell media Inﬂuence of sedimentation and diffusion
on cellular uptake
De Paoli Lacerda (2010) [61] Au NPs Protein solutions Interaction of NPs with human blood
proteins
Dominguez-Medina (2013) [62]  Au NPs (citrate coated) PBS and BSA solutions Synthesis of advanced NPs  to prevent
aggregation
Fatisson (2012) [63] Au NPs Complete cell media Impact of cell  culture media components
on stability
Hühn  (2013) [64] Au NPs (negatively and positively
charged polymers)
Complete cell media with increasing
complexity
Charge-dependent  interactions with
proteins and cells
Kittler  (2010) [65] Ag NPs (PVP or citrate coated) Complete cell media Effect of proteins on dispersability and
biological activity of NPs
Lankoff (2012) [66] Ag NPs Complete cell media (5% FBS) Impact of aggregation on cellular response
Li  (2015) [67] Cu NPs Complete cell media Dissolution of NPs in cell culture media
Liu  (2012) [68] Au nanorods (CTAB coated) BSA, HSA, IgG Interaction with proteins
McCuspie (2011) [69] Ag NPs (BSA coated) Synthetic lung ﬂuid Dispersion stabilization of NPs and effect
on colloidal stability
Mahl  (2010) [70] Au NPs (TPPTS and PVP coated) Complete cell media (FBS up to 10%) Stability and aggregation; Impact on
cellular response
Montes-Burgos  (2010) [71] Au NPs Human blood plasma Protein adsorption and stability
Moyano (2014) [72] Au NPs (sulfobetain headgroups) Diluted human serum Synthesis of corona-free NPs
Mukherjee (2014) [73] Ag NPs Complete cell media Impact of physiological interactions on
cellular dosimetry
Murdock  (2008) [13] Cu and Ag NPs Complete cell media Characterization of NP dispersion in cell
media
Pal  (2014) [74] Ni NPs Complete cell media Characterization of NP dispersion in
complex media and dosimetry
Pyshnaya (2014) [75] Au nanorods and spheres (PEI and BSA
coated)
Complete cell Impact of physiological ﬂuids on size and
stability
Soliman  (2015) [76] Au nanorods Complete cell media Method development to  improve stability
in media
BSA, bovine serum albumin; PVP, polyvinyl pyrrolidone; PEI, polyethyleneimine; FBS, fetal bovine serum; DMEM,  Dulbecco’s modiﬁed Eagle’s medium; RPMI, Roswell Park
Memorial  Institute medium; LSPR, localized surface plasmon resonance; HSA, human serum albumin; TF, transferrin; TPPTS, tris(sodium-m-sulfonatophenyl)phosphine.
physiological ﬂuids. Approaches described in more detail include:
dynamic light scattering (DLS) (Table 1), optical spectroscopies,
in particular UV–is and microscopy, with a  special focus on dark
ﬁeld hyperspectral imaging (DF-HSI) (Table 2), in  addition to an
overview of less commonly used techniques. It should be noted,
however, that there is rarely one technique that can fully char-
acterize a NP in a  physiological ﬂuid and often the most reliable
conclusions will be drawn from an array of complementary mea-
surements.
3.1. Scattering
Due to easy sample preparation and a simple experimental pro-
cedure as well as the availability of high-quality instruments, DLS
is usually one of the ﬁrst techniques to probe (plasmonic) NPs. It
is also the most abundantly used in particular in the context of
physiological ﬂuids (Table 1).
Theoretical results are available for many particle morphologies
as well as for aggregates and agglomerates of spherical particles,
which are however most frequently attributed with the features
of statistically self-similar random mass fractals. Light scattering
builds on the experience that an interaction between the NPs and
biomolecules will be accompanied by changes in the hydrodynamic
size of the particles. The constituent of the ﬂuids may  have an
impact on stability [63], and therefore, the most frequent use is to
answer whether the system remains stable or undergoes aggrega-
tion [13,28,59,60,65,69,75].  It  has been repeatedly shown that the
degree of aggregation has an impact on cellular response [70,77]
and much effort is dedicated to improve the stability of NPs in such
media [76]. Although it has been demonstrated that protein adsorp-
tion can generally stabilize the system [62,68,71], surface-charge
dependent interactions must be also considered [64]; characteriz-
ing the extent and time evolution of protein adsorption may  bring
further insights [60,72]. Other studies have used the method to
study kinetics of aggregation and dissolution of e.g. Ag  and Cu par-
ticles [67]. Two  very important factors to  be considered are particle
polydispersity [78] and the variety of the physiological ﬂuids. Since
DLS is an ensemble technique where billions of scattering centers
are probed simultaneously, proteins, which are highly abundant
in complex ﬂuids, contribute to  scattering and if this contribution
is not negligible compared to the NPs, e.g. at low concentrations,
the analysis and interpretation must allow distinction between
scattering from NPs and those proteins. This may  be achieved by
characterizing the physiological ﬂuid alone without NPs, the NPs
in an ‘empty background’ e.g. in  water, and then ﬁnally the NPs
in the ﬂuid. Nonetheless, this approach is  valid only if the interac-
tion between NPs and the proteins is  moderate, in the sense that
the overall number of ‘free’ proteins does not change considerably.
However, as soon as NP-protein complexation occurs, this approach
should not  be followed, as the ‘reference scattering’ from the pro-
tein alone is not valid anymore. In this regard depolarized scattering
provides a promising alternative to  characterize NP in physiological
ﬂuids, which relies on the optical anisotropy of even spherical plas-
monic NPs [79], which either stems from shape and/or from internal
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Table  2
Studies on plasmonic NPs in physiological ﬂuids using spectroscopic or microscopy methods.
Reference NP type Fluid(s) Content
Dark ﬁeld microscopy & hyperspectral imaging (DF-HSI)
Badireddy  (2012) [83] Ag, Au but also CNT, CeO, TiO2 NPs
(citrate  and PVP coated)
Water and simulated waste water Detection and characterization of  NPs in
complex (waste) water
Hu (2008) [84] Au nanorods and shells Water Understanding factors that inﬂuence LSPR
of NPs
Huang  (2006) [85] Au nanorods and spheres (antibody
coated)
Complete cell media and intracellular Au nanorods for photothermal therapy
Jenkins (2015) [81] Au  NPs (citrate coated) Blood Monitoring LSPR for aggregation studies
Leclerc  (2014) [86] Ag NPs (bare and cysteine coated) Complete cell media and intracellular Dissolution and reformation of silver NPs
Mortimer  (2014) [87] Ag, Au, CuO, TiO2,  NPs and QDs Intracellular and 10 mM HEPES
buffer
Semi-quantitative analysis of cellular
uptake
Rosman (2012) [88] Au nanorods and spheres (NH2- or
COOH-PEG coated)
Intracellular Assessment of NP  uptake and aggregation
inside cells
Stacy (2013) [89] Au nanorods (tannic acid coated) Water and cell culture media Detection of nanorods in cells
Transmission electron microscopy (TEM)
Hirsch (2014) [77] Au NPs Water Cryo-TEM; Effect of surface charge on
colloidal stability and cell interaction
Hondow (2012) [90] Au  NPs and QDs McCoy’s 5A (modiﬁed) Media
containing  10% FBS
Cryo-TEM; Quantitative characterization of
NP  aggregation
Rosman  (2012) [88] Au nanorods and spheres (NH2- or
COOH-PEG coated)
Intracellular Assessment of NP  uptake and aggregation
inside cells
Zhang (2014) [91] Au spheres (Citrate coated) Water Interaction between biomolecules and Au
Fluorescence  spectroscopy
De  Paoli Lacerda (2010) [61] Au NPs Protein solutions Interaction of NPs with human blood
proteins
Huang (2014) [92] Au NPs (thiol group containing
coatings)
PBS and BSA  solutions Conformational changes of adsorbed
proteins on NPs
Maffre  (2011) [93] FePt NPs (amphiphilic polymer
coated, ﬂuorescently labeled
Protein solutions Characterization of protein adsorption on
NPs
UV–Vis
Albanese  (2011) [57] Au NPs (TF coated Au aggregates) RPMI Effect of aggregation on cell uptake and
toxicity
Balog  (2015) [58] Au NPs (citrate, COOH-PEG, NH2-PEG
and  methoxy-PEG coated)
DMEM,  complete DMEM Characterizing NPs in physiological ﬂuids
Chanana  (2013) [94] Au  NPs (protein coated) PBS protease solution Properties of protein-coated NPs before
and after proteolytic digestion
De Paoli Lacerda (20100 [61]  Au NPs Protein solutions Interaction of NPs with human blood
proteins
Dominguez-Medina (2013) [62] Au NPs (citrate coated) PBS and BSA  solutions Synthesis of advanced NPs to  prevent
aggregation
Garcia (2015) [95] Au nanorods and spheres (glycan and
PEG-coated)
10%  FBS in PBS and DMEM Stability and targeting in protein rich
media
Pyshnaya (2014) [75] Au nanorods and spheres (PEI and
BSA coated)
DMEM containing 10% FBS Impact of physiological ﬂuids on  size and
stability
McCuspie  (2011) [96] Ag NPs (BSA coated) Synthetic lung ﬂuid Dispersion stabilization of NPs and effect
on colloidal stability
Jenkins (2015) [81] Au  NPs (citrate coated) Blood Monitoring LSPR for aggregation studies
Kah  (2014) [97] Au nanorods (amphi-philic ligands
coating)
RPMI Effect of NP  coating on  cellular response
Mahmoudi (2011) [98] Magnetic NPs (Au coated) FBS solution Enhancement of uptake via carbon
nanotubes
Oster-meyer (2013) [48] BSA coated Ag NPs and
Alginate-coated  Au NPs
HEPES buffer and wastewater Dissolution through LSPR changes
Soliman (2015) [76] Ag prisms, Au spheres and nanorods
(amphi-philic polymer coated)
DMEM and DMEM containing 10%
FBS
Method development to improve stability
in media
Tebbe  (2015) [99] Au nanorods (protein coated) DMEM and DMEM containing 10%
FBS
Stability of protein-coated NPs in media
Zhang  (2014) [91] Au spheres (citrate coated) Water Interaction modes of biomolecules with
NPs
Zook  (2011) [82] Ag NPs (PEG coated) DMEM containing BSA Studying the dissolution rate of Ag NP in
media
Surface-enhanced Raman spectroscopy
Fu (2015) [100] AuNPs (HSA coated) Water Overtime structural changes of serum
albumin and NPs interactions
Jenkins (2015) [81] Au NPs (citrate coated) Blood Monitoring LSPR for aggregation studies
BSA, bovine serum albumin; PVP, polyvinyl pyrrolidone; CNTs, carbon nanotubes; QDs: quantum dots; CTAB, cetyl trimethylammonium bromide; PEG, polyethylene glycol;
PEI,  polyethyleneimine; FBS, fetal bovine serum; DMEM,  Dulbecco’s modiﬁed Eagle’s medium; RPMI, Roswell Park Memorial Institute medium; LSPR, localized surface
plasmon resonance; MS:  mass spectrometry; OES: optical emission spectrometry; HSA, human serum albumin; TRIS: tris(hydroxymethyl)aminomethane; TF: transferrin.
anisotropy. It has been shown that, compared to plasmonic NPs,
scattering of depolarized light from the physiological ﬂuid is weak,
and thus, excellent ‘contrast’ with an essentially zero background
can be obtained [58].
3.2. Spectroscopic and microscopy methods (Table 2)
Compared to  the previously described scattering methods, opti-
cal spectroscopy is  a  rapid and facile technique to monitor the
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Fig. 4. (A) Extinction spectra of the single Au NPs and two  different sizes of Au agglomerates. Cryo-TEM images of (B) single Au NPs and the two  types of Au agglomerates
(C, D). Reproduced by permission of The Royal Society of Chemistry (http://pubs.rsc.org/en/Content/ArticleLanding/2014/NR/c4nr00460d#!divAbstract) [77].
colloidal behavior of plasmonic NPs. As explained before, these
particles present LSPRs, which are strongly sensitive toward aggre-
gation: individual LSPRs can couple with each other via near-ﬁeld
interactions [53,54], resulting in changes to the position, width,
and intensity of the LSPR band. As  a  consequence, particle aggre-
gation typically results in a  red-shift and a  broadening of the LSPR
absorption peak [77,80].
These  changes indicate a  decrease in the concentration of sin-
gle NPs, conﬁrmed by a  color shift of the colloid, e.g. from deep
red to purple for Au nanospheres and from yellow to black for Ag
nanospheres. Therefore, many studies have reported the colloidal
behavior of plasmonic NPs in  biological media with UV–Vis Balog
et al. [58] demonstrated that citrate coated Au NPs aggregated in
10% FBS supplemented cell culture media, while PEG-coated Au
NPs were completely stable. Plasmonic NPs functionalized with
various surface ligands, such as Au and Ag  NPs with dodecyl
grafted poly(isobutylene-alt-maleic-anhydride) or glycan-coated
Au nanorods [95], have been recently prepared by various groups in
order to improve colloidal stability in protein-rich environments.
Albanese and Chan [57] developed a simple technique to produce
transferrin coated Au NP aggregates of different sizes and char-
acterized their colloidal stability through the changes of the LSPR
band. Although UV–Vis can readily distinguish primary NPs from
agglomerated  plasmonic NPs, the signal can be compromised by the
extremely high optical density and opacity of some physiological
ﬂuids, e.g. blood [81] (Fig. 4).
UV–Vis spectroscopy has also been used to  study, and even
quantify, the dissolution of plasmonic NPs. Zook et al. [82] and
Ostermeyer et al. [48] quantiﬁed Ag NP dissolution by measuring
the LSPR intensity over time and comparing the sample’s inten-
sity against the LSPR intensity of a  Ag NP standard curve. Unlike
most existing methods, the estimation of Ag  dissolution by  UV–Vis
allows the measurement of the concentration of Ag0 within the
NPs even in  complex ﬂuids containing chloride anions at very high
concentration, since dissolved Ag+ or AgCl particles do not  have an
associated LSPR band. In addition, no separation step is  required
to separate the particles from the dissolved species. However, this
method only applies for single Ag NPs since the aggregation process
will also affect the LSPR intensity.
In  certain cases, UV–Vis is suitable for monitoring particle-
protein interactions as the LSPR is sensitive to the local dielectric
environment [54]. For this, plasmonic NPs are incubated in  media
of interest and, due to  the formation of a  protein corona, their LSPR
exhibits a  slight red shift and an increase in intensity over time.
Many papers have used the technique for this purpose, as shown in
Table  2. Protein adsorption on Au  and Ag NPs has been investigated
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Fig. 5. Dark ﬁeld micrographs of A431 cells incubated with 25  nm anti-epidermal growth factor receptor Au NP  conjugates at 4 ◦C (a) 25 ◦C (b) and 37 ◦C (c) with the
corresponding TEM of identical samples (d, 4 ◦C; e, 25 ◦C; and f, 37 ◦C) and mean scattering spectra per cell (g, 4 ◦C; h, 25 ◦C; and i,  37 ◦C). (j)  Schematic of the correlation
between  epidermal growth factor receptor regulation state and color of scattered light. Reprinted with permission from Nano Letters 2009, 9 (10), pp. 3612–3618. Copyright
2009 American Chemical Society [105].
for different types of proteins, such as BSA [96], HSA, globulins,
ﬁbrinogen, histones, insulin [61] as well as for serum [98]. While
the approach works well for bare or small molecule coated NPs
such as citrate coated Au and Ag NPs, care should be  taken when
particles are coated by  polymers, a  very common situation. The
polymer shell may  act as a dielectric spacer and thus decrease the
signal upon protein binding, i.e. the increase in  refractive index due
to protein binding should be close to  the plasmonic NP surface in
order to have a detectable shift in the LSPR [101]. Balog and col-
leagues [58] showed that BSA adsorption can be detected for citrate
coated Au NPs by UV–Vis as a  red-shift of the LSPR, from 519 to
524 nm.  However, coating of the Au  NPs with PEG did not result
in any change of the LSPR band. Therefore, UV–Vis can become
practically insensitive under certain conditions and monitoring the
protein adsorption of such surface functionalized NPs in  biological
media only by UV–Vis is not necessarily conclusive and comple-
mentary techniques should be used. An alternative technique to
study protein adsorption is ﬂuorescence spectroscopy, exploiting
the plasmonic NPs’ ability to quench the ﬂuorescence of molecules
near the particle surface. The quenching efﬁciency for metallic
NPs depends on the distance between the quencher and the chro-
mophore, therefore measurements of quenching by proteins can
reveal information about the NP-protein interaction. Moreover, the
change in the ﬂuorescence emission maxima arises from a  change
of protein conformation, which provides additional information
on the protein–particle interaction. In addition, protein adsorption
can be studied by ﬂuorescence correlation spectroscopy through
a decrease in the diffusion coefﬁcient of the chromophore corre-
sponding to an increase in particle size upon protein binding [93].
However, the technique is restricted to  ﬂuorescent compounds or
ﬂuorophore-functionalized NPs, which often bear other challenges
[102].
In contrast to  the ensemble characterization methods of UV–Vis
and ﬂuorescence spectroscopy, it is now possible to  obtain spectral
scattering information on a single NP level with high spatial res-
olution through the use of dark ﬁeld microscopy (DFM) [103]. In
a nutshell, DFM is  when white light is  focused obliquely onto the
sample, using a  specialized condenser, and only scattered light is
collected by the objective. This light can then be analyzed to  give
a hyperspectral image, i.e. every pixel of the recorded image has
an associated extinction spectra. Given the incredible scattering
cross-section of plasmonic NPs (e.g.  a  50 nm gold sphere has a  scat-
tering cross-section up to 106 fold larger than a  ﬂuorescent dye  or
quantum dot [104], their unique spectrum, and their sensitivity to
changes in the local dielectric environment, it is  possible to detect
and characterize plasmonic NPs in a  variety of complex biological
ﬂuids and tissues. An example of this is shown in Fig. 5 where DF
hyperspectral imaging was used to  follow the journey of Au NPs
upon endocytosis: small clusters of NPs that scatter green light are
present in  early endosomes, before they are trafﬁcked to late endo-
somes that scatter red light due to the formation of larger clusters
[105].
One of the earliest applications of DFM was demonstrated by
Schultz et al. who  could detect and spectrally characterize differ-
ent sized Ag NPs, as well as locate their speciﬁc binding location on
a Drosophila chromosome [106]. In a similarly pioneering study,
Huang et al. used DFM to  show the preferential binding of Au
nanospheres and nanorods to  cancer cells over healthy cells after
functionalization of the NPs with a  targeting moiety [85]. Both
these studies, among others [107], have applied DFM mostly as a
qualitative technique to conﬁrm the presence, and approximate
abundance, of the NP of interest. However, as is  often the case with
microscopy, extracting quantitative characterization data about the
state of NPs in biological ﬂuids can be challenging.
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The complexity of interpreting hyperspectral images of plas-
monic NPs is most evident by considering the simpliﬁed case of
a single NP, where the group of Gregory Hartland, among others,
has explained the factors contributing to  the observed linewidth
of a single NP’s LSPR [84]. While the NP shape and surface area
inﬂuence their scattering spectra, the presence of surface bound
proteins and other nearby plasmonic NPs, as for the case of agglom-
erates, can have a  drastic, and often challenging to predict, inﬂuence
on the spectra–as described in  the previous section for the case of
UV–Vis spectroscopy. Badireddy et al. chose to consider only sin-
gle Ag NPs with spectra that matched reference spectra, of Ag NPs
in water, in order to count their relative abundance in  simulated-
wetland ecosystem water and wastewater depending on their
surface functionality, despite the presence of aggregates [83]. Con-
versely, Mortimer et al. used reference spectra of NPs dispersed in
a cell culture buffer containing extracellular substances, thereby
taking into account any ﬂuid-dependent aggregation, resulting in
higher numbers of NPs inside the protozoa found compared with
when a reference spectra of NPs in water alone was used [87].
Furthermore, they indicated the applicability of semi-quantitative
DFM to Au, Ag, Cu oxide, and QDs; however, as in other cases an
orthogonal quantiﬁcation technique, such as ICP-MS or TEM, would
have helped validate their approach. A  noteworthy example of how
DFM can be combined with other techniques was  demonstrated by
Rosman et al. who used DFM as a low resolution semi-quantitative
method to count the number of aggregates present, which was
then combined with TEM to identify the number of particles per
aggregate [88].
Contrasting with DFM, TEM is likely the most widely applied
tool for NP characterization. However, in  the case of physiologi-
cal ﬂuids it is not usually possible due to the high concentration
of salts and proteins present which scatter and absorb the elec-
tron beam. In addition, drying artifacts [108] are a well-known
phenomenon when preparing TEM grids with NPs. One of the few
reliable ways to image NPs in, diluted or simulated, physiologi-
cal ﬂuids is through cryo-TEM, as shown by Hondow et al. who,
after plunge freezing could measure the size and packing fraction
of quantum dot agglomerates even in  the presence of FBS [90].
One of the major drawbacks, however, of cryo-TEM is the expertise
and time required to obtain well-prepared samples and perform
reliable imaging.
3.3.  Other analytical techniques
As  shown in previous sections, each analytical method has its
own advantages and disadvantages, which is  why researchers typ-
ically resort to a multifaceted approach. Not only new methods are
being developed to help characterize NPs but also methods used
in different ﬁelds of science have begun to ﬁnd their way into the
ﬁeld and help assess the question of accurate NP characterization.
Thanks to advancements in  recent years in the instrumental
setup and data acquisition techniques analytical ultracentrifuga-
tion (AUC) has become an interesting alternative to  measure the
size and shape distributions of NPs, and an increasing number of
groups have applied this method [82,86]. The theory behind the
AUC is using a centrifuge at high rotational speeds, which causes
sedimentation in a  colloidal suspension. By tracking the different
sedimentation velocities of the NPs, estimations can be made about
the size and shape distribution of a  given sample [109–111]. Zook
et al. [82] used this method to measure the size distribution of Au
NP agglomerates in situ. They were able to distinguish between
monomers, dimers, and trimmers, which is non-trivial with DLS.
Although AUC proves to be able to  bypass problems of in situ
measurements, certain assumptions about e.g. coating densities,
NPs’ and agglomerate’s morphology, or  absorbance behavior, are
required for analysis [82].
Gel  electrophoresis is an established method for protein sepa-
ration and analysis in biochemistry, but can also be  used to analyze
the interaction between NPs and proteins. Gel electrophoresis is
based on the fact that charged molecules or  particles move at dif-
ferent velocities, according to  their charge to  size ratio, when in
an electric ﬁeld. This enables the separation and quantiﬁcation of
different species. Moyano et al. [72] used gel electrophoresis to
determine the interaction between NPs and proteins in diluted
human serum. They observed that the NP mobility was affected
due to  protein corona formation. The limitation of the methodol-
ogy was that no deﬁnite results could be achieved due to  the low
mobility of NPs in the agarose matrix. A possibility to circumvent
this low mobility is  to switch to a  liquid separation medium. Le Saux
et al. [112], Ibrahim et al. [113] and Liu et al. [114] have shown that
capillary electrophoresis might be  a  suitable alternative to separate
and/or determine properties of larger analytes.
In addition to the previous mentioned methods several other
methods deserve to  be mentioned. With isothermal titration
calorimetry Huang et al. [92] were able to  study the interaction
between NPs and adsorbed proteins. The same group also used
circular dichroism spectroscopy (CD) to  analyze the structure of
BSA adsorbed to  the surface of Au NPs. By measuring bound an
unbound BSA they determined that the secondary structure of BSA
adsorbed to the NP remained intact. Tunable nanopore resistive
pulse sensing is  an interesting new technique for measuring NP
size distributions. NPs pass one by one through a  nanopore induc-
ing a  change in  current, and by tuning the size  of the nanopore,
Pal et al. have shown that accurate size distributions of nanopar-
ticles could be determined [74]. Taylor dispersion analysis is  also
an alternative to  traditional characterization techniques. Oukacine
et al. [115], Le Saux et al. [112] and others [116] have shown that
Taylor dispersion, although much less sensitive to  polydispersity
than e.g.  DLS, is  advantageous in certain cases and estimates particle
size accurately.
The  most common methods used to measure the concentration
of NPs, as well as dissolution ratios, are inductively coupled plasma-
optical emission spectroscopy (ICP-OES), and mass spectrometry
(ICP-MS). ICP is  typically rapid, high-throughput, quantitative and
extremely sensitive [117]. In this respect, ICP spectroscopies have
been utilized to quantify the total content and dissolution rate of
a wide range of plasmonic NPs, as shown in Table 2. The potential
of ICP-MS in  single particle mode has been explored as a technique
to simultaneously determine size and ultra-trace concentration of
NPs in suspension. If a  sufﬁciently dilute suspension of  NPs is  neb-
ulized into the plasma without previous digestion, a  burst of ions
is generated when each discrete particle is  vaporized, atomized,
and ionized. The ions of the element of interest are subsequently
counted with a  very high frequency, similar to the time scale of
a particle event [118]. Particle aggregation can also be detected
by monitoring the increase in signal intensity [81]. By collecting a
large number of data points, particle size distributions can also be
determined [119].
For  determining changes in NP surface charge, Laser Doppler
Electrophoresis and similar techniques have proven to be effective
methods. Many groups have shown that zeta potential analysis is
a  useful complementary method for measuring not only the efﬁ-
ciency of particle functionalization, but also protein adsorption
onto NP surfaces [58,75,91].
4.  Conclusion and outlook
Understanding the behavior of NPs in  physiological ﬂuids is
essential in  order to  study their cellular uptake, intracellular traf-
ﬁcking or fate. Extensive research in  the bio-nano ﬁeld has been
dedicated to NP synthesis, surface derivatization and possible cel-
lular reactions. However, in order to  translate nanomedicine from
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bench to bedside and to evaluate possible risks, a comprehensive
characterization of the particles is needed not only after synthe-
sis, but in the respective physiological ﬂuid that the NPs are going
to encounter. Since plasmonic NPs are excellent probes for many
analytical techniques that rely on light scattering and absorption,
research is often carried out with Au or Ag NPs. In this review,
we have presented different methods that are nowadays used for
the detection and quantiﬁcation of plasmonic NPs in  physiological
ﬂuids. In order to understand NP behavior in  physiological envi-
ronments, it is not enough to only supply robust and universal
characterization methods but also to be aware of their limita-
tions, and apply, whenever possible, more than one technique
[41].
Looking forward, it is apparent that the ﬁeld merits further
investigation. It has to be noted that the majority of published
studies are performed with NPs incubated in serum completed
cell culture media. However, NPs for biomedical applications will
be systemically injected, ingested or inhaled. Therefore, a particu-
lar emphasis on more realistic physiological ﬂuids such as blood,
mucus etc. should be given in future studies.
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